Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

By Konishi E.   Yamaoka M.   Kurane I.   Mason P.W.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1133-1139

Elsevier

Access to resources Recommend Favorite

Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice

By Ocazionez Jimenez R.   Lopes da Fonseca B.A.  

Vaccine, Vol. 19, Iss. 6, 2000-11 ,pp. : 648-654

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

By Kanesa-thasan N.   Sun W.   Kim-Ahn G.   Van Albert S.   Putnak J.R.   King A.   Raengsakulsrach B.   Christ-Schmidt H.   Gilson K.   Zahradnik J.M.   Vaughn D.W.   Innis B.L.   Saluzzo J.-F.   Hoke Jr C.H.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3179-3188

Elsevier

Access to resources Recommend Favorite

Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice

By Konishi E.   Terazawa A.   Fujii A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3713-3720

Elsevier

Access to resources Recommend Favorite